Results 171 to 180 of about 340,267 (341)

Dolichocolon is common in pediatric gastroenterology patients with constipation and associated complaints

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Dolichocolon (DC), classified under ICD‐10 code Q43.8 (“Other specified congenital malformations of intestine”), refers to an elongated or redundant large intestine. Recent studies in adults indicate a role for dolichocolon in constipation and disorders of gut‐brain interaction.
David Simon   +10 more
wiley   +1 more source

Chronic Constipation With a Rare Complication of Ischemic Stercoral Perforation of the Rectum: A Case Report [PDF]

open access: diamond
Osama M ESayed   +4 more
openalex   +1 more source

Functional constipation refractory to medical management: The anal sphincters are the problem

open access: diamond, 2023
Laura Tiusaba   +10 more
openalex   +1 more source

Recovery from symptoms using an extensively hydrolyzed formula with synbiotic in infants with presumed cow's milk allergy

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objective Extensively hydrolyzed formulas (eHF) are the first‐line approach for cow's milk protein allergy (CMPA). This study evaluated the effects of eHF with synbiotic eHF (SeHF) on the general condition and symptoms of presumed CMPA infants during the initial 4‐week exclusion diet period.
Anaïs Lemoine   +3 more
wiley   +1 more source

The association of baby‐led weaning and picky eating in children aged 2–5 years

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Baby‐Led Weaning (BLW) has been anecdotally linked to healthier eating habits and lower picky eating tendencies, yet empirical evidence remains limited. This study investigates the association between BLW and picky eating in children aged 2–5 years, comparing it with traditional spoon‐feeding methods. Methods A cross‐sectional study
Francesca Denise Monica G. Layug‐Dionglay   +3 more
wiley   +1 more source

First‐Line Osimertinib in Patients with EGFR‐Mutant Advanced Non‐Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study

open access: yesThe Oncologist, EarlyView., 2021
Abstract Lessons Learned Osimertinib has confirmed effectiveness in this real‐world population of patients with EGFR‐mutant advanced non‐small cell lung cancer. Thromboembolic events occur more frequently than previously reported, suggesting a thrombotic diathesis that requires further investigation. Patients with at least three metastatic sites, brain
Martina Lorenzi   +21 more
wiley   +1 more source

Treatment of chronic constipation with lactulose syrup: results of a double-blind study. [PDF]

open access: bronze, 1968
A. Wesselius-De Casparis   +3 more
openalex   +1 more source

Health‐related quality of life in youth with chronic gastrointestinal disease following a biofeedback enhanced cognitive behavioral therapy intervention: A randomized controlled trial

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Pediatric patients with chronic gastrointestinal (GI) conditions including inflammatory bowel diseases (IBD) and irritable bowel syndrome (IBS) on average endorse lower health related quality of life (HRQOL) than their healthy counterparts.
S. Taylor Younginer   +6 more
wiley   +1 more source

Patient‐Reported Outcomes with Selpercatinib Among Patients with RET Fusion–Positive Non‐Small Cell Lung Cancer in the Phase I/II LIBRETTO‐001 Trial

open access: yesThe Oncologist, EarlyView., 2021
Abstract Background LIBRETTO‐001 is an ongoing, global, open‐label, phase I/II study of selpercatinib in patients with advanced or metastatic solid tumors. We report interim patient‐reported outcomes in patients with RET fusion–positive non‐small cell lung cancer (NSCLC).
Anna Minchom   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy